Advances in chemotherapy for gynecologic cancer

✍ Scribed by Julian P. Smith; Felix Rutledge

• Publisher: John Wiley and Sons
• Year: 1975
• Tongue: English
• Weight: 429 KB
• Volume: 36
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/1097-0142(197508)36:2+<669::aid-cncr2820360809>3.0.co;2-a

✦ Synopsis

Considerable progress is being made in the chemotherapy of some gynecologic cancers. A random study comparing postoperative irradiation therapy with chemotherapy shows the two to be equally effective. Chemotherapy has the advantages of added safety and of being much less expensive for the patient.

Postoperative chemotherapeutic treatment with VAC of patients with embryonal carcinoma of the ovary can prevent recurrence of this frequently fatal tumor. In some patients with advanced embryonal carcinoma of the ovary, chemotherapy with VAC may produce permanent remissions. Combined irradiation and chemotherapy with vincristine and actinomycin-D may be curative for some patients with advanced sarcomas in the pelvis or abdomen. This treatment combination is associated with severe complications; however, some are preventable.